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The immune system is a  complex network of cell lineages and differentiated 
subsets that interact when exposed to foreign antigens.  To simplify the study of 
discrete cell to cell interactions many laboratories have taken  the approach  of 
using monoclonal populations of cells as model systems in which to analyze this 
complex interactive  network.  In  the  B  cell  lineage,  this  has  been approached 
through the use of B cell tumors (1,  2) and B  cell hybridomas (3, 4).  Similarly, 
for the  T  cell  lineages,  others  used  cloned continuous  cell lines  (5,  6),  T  cell 
tumors (7,  8), and  T  cell hybridomas (9,  10).  Recently, Ricciardi-Castagnoli  et 
al.  (1 1) have adapted the technique of immortalizing normal functional T  cells 
by the infection of selected normal cells with  routine radiation  leukemia virus, 
RadLV.1  Such an approach has resulted in the production of a  leukemic T  cell 
line with a stable suppressor activity (12). 
For the T  suppressor  cell subset a  number of laboratories have described a 
variety of secreted factors that mediate suppressor function. These have included 
suppressor factors that bind antigen (13-15), factors that identify variable regions 
of Ig (16),  suppressor  factors that  bind to isotypes of Ig (17), and a  variety of 
suppressor factors that are partially encoded by genes of the MHC (13-19). The 
biochemical characteristics of these T  cell suppressor factors are equally diverse 
(20-22).  The  precise  biochemical  structure  of T  suppressor  factors  (antigen- 
specific  or  nonspecific)  or  of  the  T  suppressor  cell  recognition  component 
remains unclear.  It suggests that a  variety of different factors and/or receptors 
are responsible for the mediation of suppressor functions in the ongoing immune 
response. Furthermore, the relationship between this T  cell subset, its biological 
function,  and  the  most  recently described  a,  /3,  and  3'  genes  that  apparently 
encode antigen-specific T  cell receptors is at this date unknown. Recent evidence 
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(23) has suggested  that suppressor  cell lines and  hybridomas  do not productively 
rearrange,  and therefore  do not presumably  use, these T  cell receptor genes fi)r 
their effector function. 
In  this  report,  we  describe  a  suppressor  factor  that  is  secreted  in  nanogram 
quantities  with  high  specific  biological  activity.  The  secreted  factor  that  is  a 
product  of a  T  cell  leukemic  cell  line,  LH-8,  we have termed  Inlmunoglobulin- 
Binding  T  cell  Suppressor  Factor (IgB-TsF).  The  factor contains  determinant(s) 
that can be recognized  by appropriate  monoclonal anti-I-J antibodies.  The  factor 
also  binds  to  unknown  determinants  in  the  Fc  portion  of some  Ig  molecules. 
Furthermore,  the  expression  of biological  suppressor  function  is  not  directly 
correlated  to the expression  of the c~,/3, and 3' chain genes of the T  cell receptor. 
Materials  and  Methods 
Animals.  Age- and sex-matched BDFI, A/J, and CAFI mice were purchased from The 
Jackson  Laboratory, Bar Harbor, ME. 
Antigens.  BSA  and  hen  egg lysozyme (HEL)  were  purchased  from Sigma Chemical 
Co., St. Louis, MO.  KLH was purchased from Cal Biochem-Behring,  LaJolla, CA. SRBC 
were purchased  from Scott  Laboratories,  Inc.,  Fiskeville,  RI. Haptenated proteins  were 
prepared as described  (24,  25).  Ring-necked  pheasant  lysozyme (REL) was a  gift of Dr. 
A. Miller,  University of California, Los Angeles. 
Cell Lines.  The  LH-8.105  line was a  gift of Drs.  L.  Adorini  (Centro  Studi  Nucleari 
Casaccia, Rome, Italy) and P.  Ricciardi-Castagnoli (University of Milan,  Milan,  Italy) (11, 
12).  The two subclones,  LH-8.1  and  LH-8.2,  were 2  of 12  subclones cloned by limiting 
dilution in this laboratory, and whose supernatants were screened for suppressive activity. 
The LH-8.1  line was shown to secrete a  very active suppressor factor, while the LH-8.2 
line  has a  minimum  of 20-50  times  less biological  suppressor  activity.  Both  lines  have 
similar growth characteristics and have been shown to be free of mycoplasma. Conditioned 
medium  from these lines was prepared by plating the cells at 5  x  105 cells/ml in RPMI 
1640  medium  with/3-ME and  20%  FCS for 48  h.  The saturation  density for both these 
cell lines is ~4  x  106 cells/ml,  with a doubling  time of 12-16  h. The supernatants  were 
then  collected  and  aliquots  frozen  or  prepared  immediately  for  purification.  FCS  lots 
were carefully screened for their ability to support growth, as well as their cell surface l- 
jb determinant(s) expression. 
All Ars-specific hybidomas were made and maintained  in this laboratory, as previously 
described (26). 
mAbs and Myeloma Proteins.  The monoclonal anti-l-J b and anti-I-J  d antibodies were a 
gift of Dr. C. Waltenbaugh,  Northwestern  University, Chicago, IL. The anti-Lyt-1, anti- 
Lyt-2, and  anti-Thy-l.2  were  obtained  from  New  England  Nuclear,  Boston,  MA.  The 
anti-MAC-1  monoclonal was a gift of Dr. J. Giorgi, University of California, Los Angeles. 
The rat anti-mouse FcR monoclonal was a gift of Dr. J. Unkeless, Rockefeller University, 
New York. The anti-L3T4 monoclonal was a gift of Dr. D. Raulet, MIT. The alloantisera, 
anti-H-2 b (B10.D2 anti-B10)  was a  gift of Dr.  H.  Eisen,  MIT. The anti-HEL hybridoma 
proteins 523-1D10,523-1G9,519-2F4,  AG5,525-5E11,  and 525-6D7 were a gift of Drs. 
E.  Sercarz and A.  Miller,  University of California,  Los Angeles. The anti-NP hybridoma 
proteins $43,  B619,  and  B6P2,  were a  gift of Dr. T.  Imanishi-Kari,  MIT. These mAbs 
were  purified  by affinity chromatography  (anti-Ars,  anti-HEL,  and  anti-NP  mAbs),  eu- 
globulin precipitation (anti-I-J and anti-FcR mAbs), protein A-Sepharose (anti-I-J mAbs), 
and~or DEAE-cellulose ion exchange chromatography (anti-FcR monoclonal). 
Fab and F(ab')2 fragments of purified mAbs were prepared as previously described (27, 
28).  Proper digestion  was confirmed by molecular sizing on Laemmli gels (29). Yields of 
5-10%  and  70-80%  were  typical  for the  digests  of the  mAbs for the  F(ab')2 and  Fab 
preparations, respectively. 
Fluoresceinated  Anti-lg and  Cell Staining.  All  fluoresceinated  anti-Ig were purchased 
fiom Cappel  Laboratories,  Cochranville,  PA. These included  fluoresceinated  goat anti- DALEY  ET  AL.  1417 
mouse Ig, F(ab')z goat anti-mouse F(ab')2 Ig, and F(ab')2 goat anti-rat Ig. Fluoresceinated 
anti-lg reagents were adsorbed with LH-8 cells before use. All primary staining reagents 
were centrifuged at  100,000 g for 45 rain before use to eliminate aggregated complexes. 
All other reagents were centrifuged at  10,000 g for 10 rain before use. 
10  6 cells to be tested were washed in PBS with 0.5% FCS and then incubated with the 
primary staining reagent  (as above) for 30-45 rain at  4°C.  The cells were washed  with 
PBS  +  0.5%  FCS  and  pelleted  three  times.  A  1:10  dilution  of the  fluoresceinated 
antibodies was made (1:50 for goat anti-mouse Ig), and  100 #l of this was added to the 
washed  pellet.  Cells  were  resuspended,  then  incubated  for  30  rain  at  4°C.  Cells  were 
again washed and resuspended for analysis in 0.5-1.0 ml of PBS with 0.5% FCS. 
Quantitative flow cytometry was performed as previously described (30). 
Immunoadsorbent columns.  5-I0  mg of purified  mAb or gamma globulin fraction of 
tissue culture medium was coupled with  ! g of Sepharose 4B (Pharmacia Fine Chemicals, 
Uppsala, Sweden) by the method of Axen et al. (31). The gamma globulin fraction from 
serum-free medium supernatants was used in the case of the anti-I-J mAbs. 
Biosynthetic Labeling of LH-8 Suppressor Factor.  A  total of 50 mCi of [35S]methionine 
(New England Nuclear) was added to 500 ml of LH-8 cells at  106 cells/ml in methionine- 
free RPMI  1640 medium with  10% dialyzed FCS. Cells were incubated for 8 h  at 37°C 
and  the  supernatants  harvested.  Supernatants  were  first  salted-out  to  50%  ammonium 
sulphate, and the supernatant was collected and further salted-out with 90% ammonium 
sulphate.  The  (50-90%)  pellet  that  had  been  shown  to  retain  _>90% of the  starting 
biological activity was resuspended  in  1/100th  of the original volume and dialyzed into 
PBS.  This  concentrate  was then  passed  over an  anti-I-JO-coupled Sepharose  column at 
4°C.  The effluent  from this  column was then  passed  over an  anti-I-Jb-coupled column 
that had been equilibrated  in PBS with  0.01%  NP-40. The column was washed with  20 
void volumes of PBS with 0.01%  NP-40 and the adsorbed protein eluted with 4 M NaC1. 
This  eluted  fraction  was  extensively  dialyzed  and  then  concentrated.  Aliquots  of all 
fractions  were  counted  in  liquid  scintillation  and  normalized  to  the  original  starting 
conditioned medium. The anti-I-jb-eluted fraction accounted for 0.04-0.06% and 0.005- 
0.01%  of the total biosynthetically labeled and secreted protein of the  LH-8.1  and LH- 
8.2 subclones, respectively. The anti-I-J  b Sepharose-eluted fractions were size-fractionated 
under nonreduced  or reduced  conditions (25%  2-ME) using  13%  acrylamide  Laemmli 
gels that were then  impregnated  with fluor (Enlightening,  New England Nuclear).  Gels 
were first dried then incubated at -70°C for 30 d with XAR-5 x-ray film (Eastman Kodak 
Co., Rochester, NY) and developed. 
Assays for LH-8  Suppressor Factor.  The assay for in vivo suppression  of the primary 
response has been previously described (12). Briefly, 100 ug of antigen emulsified in CFA 
was injected intraperitoneally on day 0. On days 1, 2, and 3 after immunization 0.5 ml of 
conditioned  medium  or purified  suppressor  factor was injected  intravenously.  Animals 
were killed on day 7 or 8 and the parathymic nodes dissected.  Pools of lymph nodes from 
3-5  animals  were  made  and  the  percent  of secretory  cells  was  tested  according  to  a 
modified Jerne plaque assay (32). 
SRBC were coupled with antigen according to published procedures (33).  Developing 
antisera  was  purchased  from  Gateway  Immunosera,  St.  Louis,  MO.  Complement  was 
obtained from Colorado Serum Co., Denver, CO. 
The in vitro suppression assays were performed according to the microculture technique 
(34), and as adapted by Fridman et al. (35). Specifically for these assays, spleen cells from 
animals that had been primed in vivo with two injections of antigen were used  14-30 d 
after the last immunization. Cultures were incubated with or without antigen at 5  x  105 
to  10  ~ cells per well.  20-100-fold dilutions of sterilized  fractions that were to be tested 
for  suppressor  activity  were  added  to  microtiter  wells  in  triplicate  or  quadruplicate. 
Cultures were fed daily for the first 4 d  with  the nutritive cocktail of MishelI et al. (34). 
Plaque assays were performed on day 5 after incubation at 37°C as described above. 
Preparation of Total Cellular RNA and Northern Blotting.  RNA from all cell lines were 
prepared according to the method of Glisin et al.  (36). Glyoxalation and electrophoresis 
of RNA was performed according to McMaster and Carmichael  (37).  RNA was blotted 1418  CHARACTERIZATION  OF  AN  Ig-BINDING  SUPPRESSOR  FACTOR 
TABLE  I 
Titration of Suppressor Activity of Subclones of LH-8 
Immuniz-  Source of  Number of 
Strain  ing anti-  conditioned  Dilution§  PFCs/106 cellsH 
gen*  medium* 
BDFI  HEL  None  --  3,340 +_ 265 
BDFI  HEL  LH-8.1  1:10  378 +  25 
BDF~  HEL  LH-8.1  1:100  1,899 +  201 
BDF~  HEL  LH-8.1  1:1,000  2,833 -  116 
BDF~  HEL  LH-8.1  1:10,000  3,244 _  301 
BDFI  HEL  None  --  1,400 +  119 
BDF~  HEL  LH-8.1  1:10  130 -  8 
BDF~  HEL  LH-8.1  t:100  200 +  37 
BDF~  HEL  LH-8.2  1:10  930 _+  117 
BDF~  HEL  LH-8.2  1:100  2,037 + 493 
A/J  HEL  None  I  4,026 --- 493 
A/J  HEL  LH-8.1  1:100  4,851  +  261 
* 100 #g of  antigen in a 1:1 emulsion of CFA was injected intraperitoneally 
on day 0. 
* Conditioned medium was made from the subclones by plating the lines 
at 5 x  105/ml in RPMI 1640 with 20% FCS. The cultures were incubated 
for 48  h  at  37°C.  The supernatants were harvested, immediately ali- 
quoted, and frozen. 
§ All dilutions were performed in PBS with 1% FCS. Animals were then 
injected intravenously with 0.5 ml of the indicated dilution on days 1, 
2, and 3 after immunization. 
H  The parathymic lymph nodes were dissected from the animals on day 7 
or  8  after immunization. Pools of 3-5  animals were then assayed in 
triplicate for the percent of secretory cells. The numbers represent the 
mean 4" SEM for the individual plaque assays. 
to nitrocellulose and hybridized to nick-translated DNA that had incorporated 3~P-labeled 
nucleotides  (38).  Nick-translated probes were labeled  to specific activities of >4  x  l0 T 
cpm/~g DNA. Blots that were probed several times were recycled by incubating them in 
60% formamide with  50 mM Tris (7.5) and 0.1% SDS at 60°C for 15 min. The cDNA 
clone (p86T5.91) for the/3 chain of the T cell receptor was a gift of Dr. M. Davis, Stanford 
University, Stanford, CA. The c~ (pHDS-58) and ~' (HDS4/203) chain genes were provided 
by Dr. S. Tonegawa, MIT. The rat a  tubulin probe was a gift of Dr. I. Lemischka, MIT. 
After the blots were  washed to  remove nonhybridized probe, the blots were autoradi- 
ogrammed overnight at -70°C  with intensifying screens (Lightening; DuPont Co.,  Wil- 
mington, DE). 
Results 
Suppressor Activity ofSubclones  of LH-8.  In Table I, the ability of conditioned 
medium from the suhclones LH-8.1 and LH-8.2 to suppress the in vivo humoral 
response to HEL is shown.  The LH-8.1  subclone showed significant suppressor 
activity with dilutions up to  1 : 100.  Some suppressor activity can even be seen in 
the  1:1000  dilution  of the conditioned  medium of LH-8.1.  However, as can be 
seen in the  second section of Table I, the  LH-8.2  subclone showed little if any 
suppressor activity at either of the dilutions presented.  This was contrasted with 
the LH-8.1-conditioned medium, which demonstrated up to 90% suppression in 
similar  dilutions.  The  lack  of  significant  suppression  by  LH-8.1-conditioned DALEY  ET  AL.  1419 
TABLE  lI 
In Vivo and In Vitro Antigen Specificity of LH-8 Suppressor Factor 
Percent suppression at a final dilution of 
conditioned medium of: 
Strain  Antigen  In vivo*  In vitro* 
1:50  1:200  1:50 
BDF~  HEL  74.6 + 8.1 (4)  0  67.3 4- 7.1  (8)  86.8 + 8.3 
BDF,  REL  36.4 + 4.3 (3)  12.0 + 5.2  (3)  ND 
BDF,  SRBC  10.6 + 3.1 (3)  9.0 + 6.2  (2)  12.2 + 4.8 (2) 
BDFI  TNP-BSA  59.1  +9.0(3)  62.7__  +  11.5  (6)  ND 
BDF,  TNP-KLH  2.5 4- 2.5 (2)  8.0 4- 8.0  (3)  78.7 4- 5.5 (7) 
BDF1  Ars-BSA  ND  86.1  (1)  ND 
BDF~  Ars-KLH  ND  40.5 4- 20.5  (3)  75.5 4- 9.5 
A/J  HEL  0  0  (2)  ND 
CAF~  TNP-KLH  ND  ND  10.1 +_4- 3.3 (3) 
* Each experiment contained 3-5 animals per group. These figures represent 
the mean percent suppression as compared with the immunized control from 
2-8 individual experiments. Suppressed mice were injected on day 0 with 100 
~g of antigen in CFA~ and then injected intravenously with 0.5 ml of a  1:50 
or 1:200 dilution of LH-8-conditioned medium on days 1, 2, and 3. 
* Primary antigen immunization was administered in vivo by the intraperitoneal 
injection of  100  #g  of antigen  in  CFA on  day  0.  Animals were  boosted 
intraperitoneally on  day 30  with  100  #g of antigen in  PBS.  Animals were 
rested 14-30 d and their spleens removed. A secondary in vitro immunization 
with antigen was made for 5 d in the presence or absence of LH-8.1-conditioned 
medium (1-2% final concentration). Spleen cells were then assayed in triplicate 
for PFCs per well. 
The  number  in  parentheses represents the  number of experiments in  this 
summation. Each experiment represents the average suppression of 3-5 ani- 
mals of dilutions of 1:50 or 1:200 of conditioned medium from LH-8 + SEM. 
The percent suppression was calculated as [(experimental -  background) + 
(untreated control -  background) ×  100]. 
medium in humoral response to HEL in the A/J mice suggests that the suppressor 
factor is partially restricted in its action.  This agrees with previous reports that 
mapped  the restriction to the I  region (12). 
Antigen  Specificity  of LH-8  Suppressor  Factor.  A  variety of different  antigens 
tested for the ability of the LH-8 suppressor factor to inhibit a  humoral response 
to them are shown  in Table  II. This ability was tested both in vivo and in vitro 
in BDF1  mice. There  appears to be an  overall hierarchy of antigens that can be 
suppressed  by  the  IgB-TsF.  The  suppression  does  not  appear  to  be  totally 
nonspecific,  in  that  the  humoral  response  to  SRBC  was  not  affected  by  any 
dilution  of the  factor.  Other  antigens,  to  varying degrees,  were  susceptible to 
suppression.  In all cases, the HEL  humoral  response was the easiest to suppress. 
Furthermore,  TNP-KLH,  an antigen whose in vivo humoral  response could not 
be suppressed,  could be suppressed  using the in vitro assay. In data not shown, 
purified  preparations  of IgB-TsF at  concentrations  10-100  times  greater  than 
that required  to show good suppression  with  HEL,  were capable of suppressing 
at least part of most humoral  responses to all antigens tested. It would therefore 
appear  that  IgB-TsF  is  "selective"  but  not  specific  in  its action.  This  selective 
nature of IgB-TsF is best shown by the differences seen between the suppressions 1420  CHARACTERIZATION  OF  AN  Ig-BINDING SUPPRESSOR  FACTOR 
TABLE  II1 
Cell Surface Phenotype of LH-8 Subclones 
Cell surface 
Cell line  1 ° Staining reagent*  staining  t 
LH-8.1 :  Goat anti-mouse Ig 
Anti-Thy-  1.2 (mAb)  ~  ++++ 
Anti-Lyt-1 (mAb) 
Anti-L3T4 (mAb) 
Anti-Lyt-2 (mAb)  + 
Rat anti-mouse FcR (mAb) 
Anti-H-2  b (KaaKb) n  ++ 
Anti-MAC-  1 (mAb) 
Anti-I-J  b (mAb/WF9.5.2)  +/- 
Anti-IoJ b (mAb/WF9.40.5)  + 
Anti-I-J  b (mAb/WF9.1.4)  ++ 
F(ab')2 anti-I-J  b (mAb/WF9.1.4)  ++ 
Anti-I-J  d (mAb) 
LH-8.2:  Goat anti-mouse Ig 
Anti-Thy-  1.2 (mAb)  ++++ 
Anti-Lyt-1 (mAb) 
Anti-Lyt-2 (mAb)  +/- 
Anti-I-J  b (mAb/WF9.40.5)  +/- 
Anti-H-2  b (K%~K  b)  ++ 
* Purified anti-I-J mAbs were diluted to ~1  mg/ml for primary staining 
of cells.  20 td of reagents was added to 100 td of PBS with 0.5% FCS 
containing 106 LH-8 cells.  Other mAbs were added at concentrations 
that  were  twice  the  amount  known  to  be  optimal  for  positive  cell 
populations. The second-step reagent in all cases was an F(ab')2, fluores- 
ceinated reagent of the appropriate specificity, which had been adsorbed 
with LH-8.1 cells.  All analyses were quantitated by flow cytometry on 
either a Cytoflnorograph H-50 (Ortho Diagnostic Systems Inc., Raritan, 
N  J) or a B-D/FACS-III (Becton Dickinson & Co., Mountain View, CA). 
Negative controls for these reagents were  MOPC-21-purifled protein 
(10 td of 1.0 mg/ml) and the second-step fluoresceinated reagents. -, a 
shift in peak fluorescence channel of less than three channels and less 
than 3% cells positive when compared with the negative control. +/-, a 
shift of 3-5 channels of peak fluorescence and/or 3-5% of cells consid- 
ered  positive.  +,  a  peak  fluorescence channel shift  of 5-7  channels 
and/or 10-20% of the cells clearly positive. ++, a shift of 7-10 channels 
and/or 20-40%  of the cells  were positive. ++++, all cells  were very 
strongly stained. 
mAb indicates that  the primary staining reagent  was an  mAb of the 
indicated specificity. 
H  Alloantisera from B10.D2 mice were raised by the repetitive immuni- 
zation of these mice with B 10 spleenocytes. 
when  HEL  or  REL  are  used as  antigens.  These  two  lysozymes are  very  closely 
related in amino  acid structure  and yet display totally different susceptibilities to 
the  suppression  of  their  humoral  response.  This  data  shows  the  necesity  of 
titrating "suppressor"  factors  that  may appear  to  be specific  in order  to  clearly 
define the level of specificity or restriction. 
Cell Surface Phenotype of LH-8.1  and LH-8.2.  In Table  IIIa  summary  of the 
cell surface  phenotype  of the  subclones  LH-8.1  and  LH-8.2  is shown.  The  cell 
surface  phenotype  of these  subclones clearly  showed  that  they  are  T  cells and DALEY  ET  AL.  1421 
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FIGURE  1.  Surface-staining of LH-8.1  cells with anti-l-J and other mAbs.  106 LH-8. cells in 
100 #l PBS were incubated for 45 min at 4°C with 30 #1 of anti-I-J  d, F(ab')z/WF9.1.4 (anti-I- 
jb), 31-64  (anti-Ars), or F(Ab')2 31-64  at concentrations of 1 mg/ml. The cells were washed 
three times with  PBS containing 0.5%  FCS,  and  then  20  #1  of fluorescenated F(ab')~ goat 
anti-mouse IgG-F(ab')2 was added and allowed to incubate 30 min at 4°C. Cells were washed 
and analyzed on a  B-D FACS Ill. Gains were set so the peak of the fluorescence profile for 
the autofluorescence controls was contained within the first 10 channels. 
that  the  LH-8.1  line  expresses  the  I-J  b  determinant,  albeit  weakly, on  its  cell 
surface. This is shown by the positive reaction with three separate anti-l-J  b mAbs. 
The possibility that the staining with the anti-I-J  b mAbs was due to nonspecific 
adherence to the cell surface via the constant region of the antibody was ruled 
out  because  of the  positive  results  with  the  F(ab')2  fragment of the  WF9.1.4 
monoclonal (Fig.  1).  It was necessary to use the divalent F(ab')2 because of the 
apparent weak interaction of the monoclonal with the cell surface I-J determi- 
nants. The lack of staining with the anti-I-J  a mAb confirmed the specificity of 
the  cell  surface  staining.  The  LH-8.2  subclone  exhibited  a  very  similar  cell 
surface  phenotype;  however,  in  parallel  experiments  there  appeared  to  be  a 
diminution of the cell surface determinants for I-J. This result correlated with 
this subclone's inability to secrete a  functional suppressor factor compared with 
the LH-8.1  subclone. In data not shown, the expression of the I-J  b determinant 
on the LH-8.1 line was dependent on the growth cycle of the subline and the lot 
of FCS. FCS lots bad to be carefully screened for their ability to support the cell 
surface expression  of l-J b,  independent of the ability of individual FCS lots to 
support the growth of the sublines. 
Binding of Various Hybridoma Proteins to the Cell Surface and Secreted Suppressor 
Factor  Product  of LH-8.1.  In  early  experiments  it  was  observed  that  some 
hybridoma proteins, originally used as controls for immunofluorescence studies, 
seemed to bind  to  the surface of LH-8.1.  In  Table  IV a  collection of various 
hybridoma  proteins  that  contain  different  antigen  specificities  and  different 
isotypes were examined for their ability to bind to the cell surface of the LH-8.1 
line (see Fig.  1). They were also examined for their ability to bind the secreted 
suppressor factor. A direct correlation was shown to exist between the phenom- 
ena of binding Ig to the cell surface of LH-8. I, and whether or not Ig coupled 
to Sepharose can adsorb the factor out of conditioned medium.  Furthermore, 
no obvious correlation can be made with the factor's ability to bind to distinct 
heavy or light chain isotypes, allotypes, or idiotypes, or to known structural genes 
responsible for antibody formation. In  the latter part of Table  IV,  it is shown 1422  CHARACTERIZATION  OF  AN  Ig-BINDING  SUPPRESSOR  FACTOR 
TABLE  IV 
Binding of Hybridoma Proteins to the Cell Surface and Secreted 
Suppressor Factor of LH-8.1 
Hybridoma  Specificity  Isotype 
Reactivity 
Cell sur-  Secreted 
face*  factor  | 
36-65  Ars  3'], K  ++  + 
45-165  Ars  T2b, x  +  + 
45-49  Ars  3'2b, K  ++  + 
31--64  Ars  "~2b, K  +  ND 
36-54  Ars  "{2b, K  -  - 
36-60  Ars  ~'2~, K  -  - 
31-62  Ars  3'~, K  -  - 
31-41  Ars  "YI, K  -  - 
523-1D10  HEL  3'1, K  +  + 
523-1G9  HEL  ~1, K  -  - 
519-2F4  HEL  T], K  -  ND 
AG5  HEL  3'1, K  -  ND 
525-5E11  HEL  3"1, K  -  ND 
552-6D7  HEL  TI, K  -  ND 
$43  NP  3"2a, kl  +  ND 
B619  NP  ~Y2a,  XI  --  ND 
B6P2  NP  #, X~  -  ND 
36-65 Fab  Ars  "~l, K  --  -- 
31--64 (Fab')2  Ars  3'~b, K  -  ND 
*  106 LH-8.1 cells were first incubated with 20 #1  of hybridoma protein 
(1  mg/ml) in a  total volume of 100/11 PBS witb 0.5% FCS. Cells were 
washed  and  then  incubated  with  5-10  #1  of the  F(ab')2  fragment  of 
fluorescenated goat anti-mouse  Ig. This second-step reagent was  first 
adsorbed with  10 ~ LH-8.1  cells per 100/A. Stained cells were analyzed 
by quantitative flow cytometry.  -, a  shift in mean fluorescence of <3 
channels and  <3%  cells positive as compared  with a  negative control 
using either MOPC-21-purified paraprotein  or 31-62  hybridoma pro- 
tein. +, a peak fluorescence channel shift of 5-7 channels and  10-20% 
of the cells considered to be clearly positive. ++, a 7-10 peak channel 
shift and 20-40% of the cells clearly positive. 
* +, 90% of the suppressor activity from conditioned medium could be 
adsorbed and subsequently eluted from the affinity column. 
that  the binding  to the cells and  the factor can  be abolished  if the  Fab  fragment 
of the mAb  is used.  In addition,  an  mAb,  31-64,  which had exhibited  cell surface 
binding  reactivity  (see  Table  IV  and  Fig.  1)  with  LH-8.1,  also  lost  this  ability 
when  one  made  the  F(ab')2  of  this  mAb  (Fig.  1).  This  data  shows  that  the 
suppressor  factor has an affinity for a  determinant  in the Fc region  of the heavy 
chain.  Complex  carbohydrates  would  seem to be likely candidates  to account  for 
such  differences.  Alternatively,  the  Fc  portion  may  be  necessary  to  stabilize 
structural  epitopes  in  the variable region  of the Ig molecule. 
Affinity Adsorption of LH-8.1 Suppressor  Factor.  Since there  appeared  to be a 
restricted  specificity  for  the  suppressor  factor  and  the  cell  surface  of  LH-8.1- 
expressed  I-J determinants,  we wanted  to find out whether  the IgB-TsF  contained 
determinants  that  could  be  recognized  by anti-I-J  mAbs.  Purified  anti-I-J  mAbs 
were  coupled  to  Sepharose  4B  and  conditioned  medium  was  passed  over  these DALEY  ET  AL. 
TABLE  g 
Affinity Purification of LH-8. I Suppressor Factor 
Hybridoma-coupled Sepharose 4B 
Relative suppression* 
Effluent*  Eluate  ° 
Anti-l-J  d  ++++  -- 
Anti-l-J  b (WF9.40.5)  +/-  ++++ 
Anti-Ars (45-49)  -  ++++ 
Anti-Ars (36-65)  +  +++ 
Anti-I-J  b (WF9.40.5) + anti-Ars (36-65)  +/-  ++++ 
* Effluent and eluates from all columns were tested using the in vivo assay 
with three log dilutions. -, no suppression was seen. +/-, a small amount 
of suppression was seen in the undiluted fractions. +, some suppression 
was seen in the undiluted fraction and the first dilution. +++,  ~70- 
90%  of the  reactivity was  recovered in  this fraction and  significant 
suppression  could  be  seen  in  even  high  dilutions. ++++,  as  much 
suppression was seen in this fraction in all dilutions as compared with a 
control of conditioned medium. Presumably, this accounts for >_90% of 
the biological activity. 
* Columns were equilibrated with PBS containing 0.05% FCS. A sample 
of concentrated LH-8.1-conditioned media (20  ×) was loaded on each 
column.  After discarding one  void volume,  two  void volumes were 
collected. The columns were then washed with 10-20 elution volumes 
of PBS before salt elution. Samples were dialyzed against PBS before 
assay. 
§ 4 M NaCI was used to elute any biological activity. A volume equal to 
two times the loading volume was passed over the column and the salt- 
eluted  fraction was  collected and  dialyzed to  an  equivalent starting 
conditioned medium concentration for assay. 
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respective columns.  Line 1 of Table V  shows that the anti-I-jd-coupled Sepharose 
column  exhibited  all  the  suppressor  activity  in  the  effluent.  However,  the 
monoclonal  anti-I-J  b  Sepharose  column  bound  the  suppressor  factor  and  this 
activity could  be  eluted  from  that  column,  as  seen  in  line  2.  Similarly,  it  was 
shown  that  the  factor  could  also  be  bound  to,  and  eluted  from,  the  column 
coupled with the anti-Ars hybridomas, 36-65 and 45-49.  It was of interest to ask 
whether  there was a  single or several distinct factor(s) that bound  to the anti-I-J 
column and the anti-Ars hybridoma-coupled  columns. 
In line 5  of Table  V, it is shown  that the anti-I-Jb-eluted factor was also found 
to bind to the anti-Ars (36-65)  column.  This suggested that a  single suppressive 
molecule (perhaps multiple chains) was responsible for the binding to Fc portion 
of Ig and contained an  I-J determinant. 
Biosynthetic Labeling and Purification of LH-8 Suppressor  Factor.  To  show that 
the LH-8 cells were indeed synthesizing and secreting the suppressor factor, cells 
were biosynthetically labeled with [35S]methionine.  Since we had shown that the 
two  LH-8  subclones  have  distinct  biological activities in  terms  of quantitative 
suppression,  we felt we were able to follow the specific proteins associated with 
suppression by comparing the labeled material from these two subclones. Biosyn- 
thetically labeled material from both subclones was concentrated and passed over 
an  anti-I-J'Lcoupled Sepharose  column.  The  effluent  was  then  passed  over  an 
anti-I-jb-coupled Sepharose  column  and  the  adsorbed  material eluted and  con- 1424  CHARACTERIZATION  OF  AN  Ig-B1NDING  SUPPRESSOR  FACTOR 
FIGURE 2.  Purification of biosynthetically-labeled LH-8 suppressor factor. Both proteins of 
LH-8.1  and  LH-8.2  were  biosynthetically labeled  with  [sSS]methionine for  8  h  at  37°C. 
Superantants were first salted-out to 50% ammonium sulphate and the pellet discarded. The 
supernatants were then salted-out to 90%  ammonium sulphate and the pellet collected and 
diluted in PBS. These concentrates were then dialyzed into PBS and passed over an anti-I-Jd/ 
mAb-coupled Sepharose 4B column and washed with 20 void volumes of PBS with 0.01% NP- 
40. This effluent was then passed over with 20 void volumes of PBS with 0.01% NP-40. The 
eluted  factors were  eluted  with  4  M  NaCI.  Eluted  fractions were dialyzed into  PBS  and 
concentrated. The eluted fractions represented 0.004 and 0.001% of the total biosynthetically 
labeled protein of the LH-8.1  and LH-8.2, respectively. Purified fractions were then loaded 
on 13% Laemmli gels under nonreduced and reduced conditions and impregnated with fluor. 
Gels were autoradiographed with x-ray film at -70 °C for 30 days and the films were developed. 
centrated.  Concentrated  material  from  both  sublines  were  electrophoresed 
through  13% acrylamide gels, then subjected to fluorography. 
The factor from the LH-8.1 subclone showed a complex pattern of bands with 
multiple molecular masses.  However,  upon reduction, a  single band was noted 
of approximately  28  kD  (Fig.  2).  Furthermore,  this  band  was also seen  in  the 
LH-8.2-purified fraction but  represented  ~5-10-fold  less material.  It was also 
observed  that  three-  to  fivefold less  total  biosynthetically labeled  protein  was 
adsorbed to the anti-I-J  b column from the  LH-8.2 subclone supernatant vs.  the 
biosynthetically-labeled material from the  LH-8.1  subclone.  Therefore,  collec- 
tively these data suggest that the  suppressor  factor from the  LH-8.1  subclone 
was indeed a single chain of ~28  kD and that this protein was made in an ~20- 
50-fold  less  amount  in  the  LH-8.2  subclone.  This  agreed  with  the  biological 
assays for these two subclones. 
Expression of the c~-, 13-, and "y-associated Genes of the Normal T  Cell Receptor  in 
the LH-8.1  and LH-8.2 Subclones.  Since  LH-8 exhibited a  phenotype that cor- 
related with a  suppressor  T  cell subset,  we were interested in whether the two 
subclones of LH-8 expressed  the T  cell receptor genes.  In Fig.  3A-C  it can be 
seen  that  both  the  LH-8.1  and  LH-8.2  express  the  C-v~, Cl-e,  and  CT~  gene 
messenger RNA, and, to the first approximation,  in equivalent quantities. The 
control for proper quantitative loading of intact mRNA is seen in Fig. 3D. This 
blot was  probed  with  the  rat  0~ tubulin  probe  as a  positive control  for all  cell 
lines. Since the LH-8.1 and LH-8.2 differ ~20-50-fold in expression of suppres- 
sor function, as well as the expression of the 28  kD protein, it might have been 
expected that the expression of the T  cell receptor genes would correlate with 
the expression of the presence or absence of suppressor function. This is clearly 
not the case for this T  cell. However, the LH-8.1  cell line is an example of a  T 
cell  that retains a  suppressor  cell  phenotype, and at  the same  time rearranges 
and expresses the CT~, CT0, and CTy genes. Previously, only T  cells of the helper 
(39) or cytotoxic (40) cell phenotype have been described to productively rear- DALEY  ET  AL.  1425 
FIGURE 3.  Northern blot analysis of expressed  genes of LH-8 subclones.  Expression  of T 
cell receptor genes in  LH-8.1  and  LH-8.2.  RNA was isolated  from a  B cell  line  (A20),  a 
macrophage line (P388.DI), and a Th hybridoma (6.2), as well as the LH-8.1  and LH-8.2 
subclones. 40 #g of total RNA from each line were glyoxalated and electrophoresed overnight 
through  1.2% agarose gel.  The  gels  were  blotted  with  nitrocellulose  and  the  blots  were 
s2  hybridized with nick-translated,  P-labeled CT=, CTa, CT~ or a-tubulin probes.  The blots were 
washed and then autoradiogrammed overnight with enhancing screens at -70°C. Molecular 
weight markers are in the margins. 
range  and  transcribe  these  T  cell  receptor  genes.  A  recent  report  also  has 
suggested  (41)  that  the  parental  LH-8.105  cell  line  expresses  the  appropriate 
antigen-specific T  cell receptor dimer on its surface.  It is interesting  to note that 
both the  LH-8.1  and  LH-8.2  line express  high levels of full  length  CT~ mRNA. 
This  gene  has  only  been  described  to  be  expressed  on  cytotoxic  T  cells  (42). 
However,  the  only phenotypic  marker  that  distinguishes  murine  suppressor  T 
cells from cytotoxic cells  is the  I-J determinant,  and  the precise  molecular basis 
for this determinant  has most recently been questioned  (43). 1426  CHARACTERIZATION  OF  AN  Ig-BINDING  SUPPRESSOR  FACTOR 
Discussion 
Since the original description of suppressor cells (44), a number of laboratories 
have  tried  to  biocbemically characterize  the  factor  responsible  for  immuno- 
suppression. These efforts have yielded a large family of factors that are capable 
of mediating suppression. These factors have equally diverse characteristics, in 
that some bind antigen (20-22); some bind Ig idiotypic determinants (45); some 
express  idiotypic determinants (16);  some bind the  Fc portion of Ig (17);  and 
some contain by  themselves, or  in  combination with other  chains,  an  MHC- 
encoded determinant. Perhaps the lack of precise biochemical data on the nature 
of many suppressor factors, even with the availability of cloned hybridomas and 
cell lines, is in part due to their inherent high specific activity and relative lability, 
very analogous to some peptide hormones. 
In this study, we describe a factor, which in nanogram quantities of protein is 
capable of suppressing the in vivo or in vitro humoral response to a variety of 
different antigens.  In terms of its  biological function, it seems to most closely 
resemble the immunoglobulin-binding factor (IBF) of Fridman et al. (35).  Our 
factor,  IgB-TsF,  does  seem  to  bind  to  several  randomly selected  hybridoma 
proteins, and like IBF this binding is restricted to the Fc portion of these mAbs. 
This was shown in this study by the lack of adsorption of the factor to an Fab 
fragment-coupled Sepharose  column, whereas  the  factor had  been  shown  to 
bind to the column coupled with the intact hybridoma protein. However, unlike 
IBF,  IgB-TsF  is  not  isotype-specific  in  its  binding  to  various  Ig.  We  have 
preliminary evidence to  suggest that  the  binding  to  the  Fc  region  is  due  to 
glycosylation  of this portion of the Ig molecule. This suggests that the recognition 
portion of this suppressor molecule might be "lectin-like". Differential glycosyl 
moieties on  the surface of various subsets or activation stages of lymphoid or 
presenting cells  might serve  to  localize and  concentrate the  action  of such  a 
suppressor factor. In  studies not shown, we have also shown that, unlike IBF, 
our factor cannot be "up-regulated" (46) by incubation with hybridoma proteins 
that bind the secreted factor. Also, IgB-TsF cannot directly inhibit the secretion 
of Ig of hybridomas that bind  the  factor.  The  lack of H-2  restriction  in  the 
mediation of the suppression for the IBF (17)  is also, in part, at odds with the 
characteristics of IgB-TsF, although such an observation could merely be dose- 
related. However, a common feature of IgB-TsF and IBF is that they are both 
associated  with  I  region  determinants.  The  molecular mass  characteristics of 
soluble IBF and IgB-TsF are also distinct, i.e., 40 kD vs. 28 kD. 
In terms of its biochemical characteristics, IgB-TsF seems to resemble the light 
chain of Tada et al. (20)  or the single chain factor of Krupen et al. (21), with 
several distinct differences. Unlike the factor of Tada et al., the IgB-TsF is only 
composed of a single peptide chain. However, like the light chain component of 
the factor of Tada et al., it is a 28 kD chain that contains determinants recognized 
by anti-I-J mAbs. This light chain is also responsible for the mediation of the 
suppressor function, although it has no effect unless associated with the 45 kD, 
antigen-binding chain. 
The factor of Wieder et al. (47)  has been described as a single peptide chain 
that can bind antigen and contains an I-J determinant; this factor has a minimal 
molecular mass of ~24  kD.  The  IgB-TsF in  this paper  would seem  to closely DALEY ET  AL.  1427 
resemble this factor, except for its lack of antigen-binding characteristics.  How- 
ever, the original  clone, LH-8.105,  from which the two subclones, LH-8.1 and 
LH-8.2, were derived, had been reported to secrete an antigen-specific suppres- 
sor factor (12). Since the two subclones were originally selected on the basis of 
the presence or absence of suppressor activity to the in vivo humoral  response 
to  HEL  and  not  for  their  antigen  specificity,  perhaps  the  LH-8.1  subclone 
represents a mutated (in terms of antigen specificity), antigen-binding moiety of 
a  factor analogous to Wieder et al.  (47).  Our limited biochemical studies have 
suggested that our factor is not lipoprotein, but is possibly a glycoprotein. 
The factor could also be a "light chain" only secretor of the factor of Tada et 
al. (20). This is clearly a common event in B cell lines and hybrids. In this case, 
however,  the  factor  also  would  have  gained  the  ability  to  express  biological 
suppressor activity as a single chain. 
Regardless of the relationship  of this factor to others previously reported,  it 
shows several  points  of significance  in  the  elucidation  of the  biochemistry  of 
secreted suppressor factors. First, the ability to bind or not bind mAbs is not, in 
and of itself, sufficient evidence for the presence of the mAb-defined determinant 
on  the  suppressor  molecule.  The  use of F(ab')2 fragments  of these mAbs can 
clearly distinguish  betweeen the  Ig-binding  property, as exhibited by our  IgB- 
TsF, and the binding due to variable region antigen recognition. Similarly, one 
must also extensively examine the nature of isotypic (17), idiotypic (16), or anti- 
idiotypic (45) determinants  associated with  T  cell  suppressor  factors.  Alterna- 
tively, one could argue that such relationships do in fact exist for our IgB-TsF, 
but that such epitopes are only recognized by the intact tertiary structure of the 
Ig  that  is  destroyed  when  F(ab')2  or  Fab  fragments  are  made.  The  further 
purification  and structural  determination  of the IgB-TsF will  hopefully resolve 
this question. 
Secondly, the antigen "specificity" of suppressor factors must clearly be defined 
over a  wide concentration,  as well as with multiple and diverse antigens.  In the 
case of the  IgB-TsF,  substantial  data  could be presented  to support  "antigen- 
specificity,"  "isotype  or  idiotype-specificity,'  etc.  Furthermore,  although  the 
overall  effect of suppression  in  the  host may indeed  be specific,  this  does not 
mean that the mediators of suppression  must also be specific. A  specific recog- 
nitive  "triggering"  event that  elicits a  nonspecific, or perhaps as in  the case of 
IgB-TsF, selective suppressor factor would also be scored as specific at the level 
of the whole animal. 
In part, the molecular basis for I-J subregion determinants on the cell surface 
and  associated suppressor  factors  has  been  called  into  question  (43),  although 
some explanation  has been offered (48). A question that can be addressed using 
a  cloned T  cell line that expresses I-J determinants  is:  What  is the relationship 
between the secreted I-J(+) suppressor factors, i.e. between the biological func- 
tion  and  the  previously  described  T  cell  receptor  genes  (39,  40)?  Perhaps 
suppressor  cells  are  merely  differentiated  stages  of helper  or  cytotoxic  cells 
(excess  help  or  self  killing).  A  great  deal  of debate  exists  over  whether  T 
suppressor cells even  use the same  family of genes as other  T  cell  subsets for 
recognitive events associated with  the elicitation  of effector function.  Only Th 
and cytotoxic T  cells have been clearly inferred to use this family of genes. The 1428  CHARACTERIZATION  OF  AN  lg-BINDING  SUPPRESSOR  FACTOR 
CT~, CTe, and  CT~  genes are  rearranged  and  expressed  for both  subclones of 
LH-8 reported in this paper.  It would also appear that either IgB-TsF secretion 
is totally unrelated to the expression of the T  cell receptor, of if they are indeed 
directly linked, then the loss of suppressor function in LH-8.2 is due to posttran- 
scriptional control of IgB-TsF expression. The cloning of the gene for IgB-TsF 
expression should clearly distinguish these possibilities. It is possible that although 
suppressor cells may indeed use a similar family of T  cell receptor genes for their 
recognitive  events associated with  their  activation,  they might  not  require  an 
intact  receptor  to  maintain  their  effector function  of suppression.  It  may  be 
productive to concomitantly use the  LH-8.1  and  LH-8.2 subclones as +  and  - 
populations to further study the gene(s) associated with suppression. 
The  origin  of the  LH-8  murine  T  cell  leukemia,  Rad-LV infection,  and  its 
associated suppressor  function  are  also of topical  interest.  The  recent  reports 
(49)  that  HTLV-III  is  the  etiological  agent  of Acquired  Immune  Deficiency 
Syndrome (AIDS) may be related to the studies in this report. Both the Rad-LV 
and HTLV, biologically similar retroviruses, may share a  tropism for certain  T 
cell subsets. Although the target cell in this disease appears to be the Th subset, 
immortalizing  and  expanding  a  T  cell clone or related  regulatory clones with 
properties  very  analogous  to  the  LH-8  murine  leukemia  could  conceivably 
enhance or further provoke an immune deficiency state very similar to that  of 
AIDS patients.  Perhaps  this  routine  system may be useful as a  model to study 
such  immunodeficient  states.  However,  this  also  raises  another  point.  Is  the 
mediator  of the suppression  a  product of a  normal  or aberrantly  expressed T 
cell product; is it a product of the retrovirus; or perhaps even a chimeric product 
of  the  retrovirus,  and  a  normal  T  cell  product?  It  is  already  known  that 
retrovirally  infected cells often  secrete an  active,  immunologically  suppressive 
protein,  P-15, which is a product of the retrovirus (50, 51).  Furthermore,  a cis 
or trans-activation  of suppressor  factor gene(s) might  occur (52).  Although  its 
biochemical and biological characteristics appear to be unrelated  to IgB-TsF, a 
chimeric  gene  of normal  T  cells  and  a  retroviral  protein  might  be  suitable 
candidates for IgB-TsF, as well as previously described suppressor factors. The 
cloning of the gene(s) responsible for suppression  in the  LH-8 T  cell leukemia 
will answer these questions. 
Summary 
A secreted product of a  T  cell leukemic cell line,  LH-8, was examined for its 
biochemical and  biological properties.  The  factor that  we have termed  Immu- 
noglobulin-Binding  T  cell  Suppressor  Factor  (IgB-TsF)  was shown  to be sup- 
pressive for the in  vitro and in  vivo humoral  response to a  variety (but not all) 
antigens tested. The cell surface phenotype of the LH-8.1 subclone was M.Ig(-), 
Thy-1(+), L3T4(-), Lyt-2(+), FcR(-), MAC-1 (-), and H-2b(+). In addition, both 
the cell surface and secreted factor, IgB-TsF, of LH-8.1 expressed determinants 
that were recognized by anti-I-J b mAbs but not by an anti-I-J d monoclonal. The 
same factor also retained  an affinity for the  Fc portion  of ~30%  of randomly 
selected, purified  mAbs.  This binding  could be abolished if the Fab or F(ab')2 
fragments of these mAb were used, but was found to be unrelated to isotype of 
the respective mAbs.  Using subclones that expressed quantitative differences in DALEY ET  AL.  1429 
their ability to exert suppression  as sources of biosynthetically labeled IgB-TsF, 
we have shown  the  suppressor activity correlated  with a  single,  28  kD protein. 
Furthermore, comparisons of these same subclones that differ in their suppressor 
activity,  do  not  show  any direct  correlation  of this  biological  activity with  the 
expression of the previously described T  cell receptor genes. It also suggests that 
at least some suppressor cell subsets may use the same or related family of T  cell 
receptor genes for their  recognitive stage of activation as helper and  cytotoxic 
T  cell subsets, but not for their effector stage of immunologic suppression. 
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